Woelfel, S.; Dütschler, J.; Junker, D.; König, M.; Leinenkugel, G.; Graf, N.; Krieger, C.; Truniger, S.; Franke, A.; Koller, S.;
et al. Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease. Vaccines 2024, 12, 774.
https://doi.org/10.3390/vaccines12070774
AMA Style
Woelfel S, Dütschler J, Junker D, König M, Leinenkugel G, Graf N, Krieger C, Truniger S, Franke A, Koller S,
et al. Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease. Vaccines. 2024; 12(7):774.
https://doi.org/10.3390/vaccines12070774
Chicago/Turabian Style
Woelfel, Simon, Joel Dütschler, Daniel Junker, Marius König, Georg Leinenkugel, Nicole Graf, Claudia Krieger, Samuel Truniger, Annett Franke, Seraina Koller,
and et al. 2024. "Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease" Vaccines 12, no. 7: 774.
https://doi.org/10.3390/vaccines12070774
APA Style
Woelfel, S., Dütschler, J., Junker, D., König, M., Leinenkugel, G., Graf, N., Krieger, C., Truniger, S., Franke, A., Koller, S., Metzger-Peter, K., Oberholzer, M., Frei, N., Geissler, N., Schaub, P., STAR SIGN Investigators, Albrich, W. C., Friedrich, M., Niess, J. H.,
... Brand, S.
(2024). Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel Disease. Vaccines, 12(7), 774.
https://doi.org/10.3390/vaccines12070774
